What Treatment for Patients With Phlebitis or Pulmonary Embolism ?

Study Overview
=================
Brief Summary
-----------------
The objective of the anticoagchoice study is to analyze the preferences of people suffering from phlebitis, in terms of anticoagulant, to improve adherence to these treatments, to adapt the medical prescriptions.

Detailed Description
-----------------
Venous thromboembolism (VTE) is the third leading cause of cardiovascular death, with an increase in annual incidence with age. With the advent of direct oral anticoagulants, the management of deep vein thrombosis and pulmonary embolism has evolved in recent years and these treatments are widely prescribed. There are studies comparing the different anticoagulant treatments used in venous thrombosis, which show no inferiority of treatment (injectable or oral) compared to others. Drug delivery modalities have been shown to affect adherence, and thus treatment efficacy. It seems fundamental to focus on patients' drug preferences in VTE to ensure the best possible compliance. These preferences seem to depend on the personal history of each patient. In addition, no studies have been conducted on patient preferences for anticoagulant therapy for VTE: this is the goal of the anticoagchoice study.

Official Title
-----------------
Patients' Choice in Terms of Anticoagulant Therapy in Venous Thrombo- Embolism Disease. AntiCoagChoice Study

Conditions
-----------------
Venous Thrombosis or Pulmonary Embolism

Intervention / Treatment
-----------------
* Other: anticoagulation choice


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients with deep vein thrombosis, superficial vein thrombosis, muscle vein thrombosis or pulmonary embolism, over 18 years of age. No Exclusion Criteria

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients with venous thromboembolic disease<br>Patients with deep vein thrombosis, superficial or muscular vein thrombosis, pulmonary embolism, over 18 years of age. | Other: anticoagulation choice<br>* Type of anticoagulant chosen by the patient (oral or injectable).<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The primary objective of this study is to analyze patient treatment preferences in venous thromboembolic disease. | The primary outcome: To compare the proportion of patients choosing oral anticoagulation vs patients choosing injectable route. | the time required for a consultation: 30 minutes | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| compare patients choosing oral anticoagulation vs patients choosing an injectable route | proportions of patients choosing an oral anticoagulation vs. patients choosing an injectable pathway depending on the duration of treatment (3 months, 6 months or more), | the time required for a consultation: 30 minutes | 
| compare patients choosing oral anticoagulation vs patients choosing an injectable route | Identify factors influencing these choices, depending on the characteristics of the patient (history, age, gender, social environment, personal experience). | the time required for a consultation: 30 minutes | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Deep Vein Thrombosis, Superficial Vein Thrombosis, Anticoagulant, Patient Compliance, Preference, Venous Thrombosis, pulmonary embolism